Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma | AllSci

Search Chat Visualize Browse

Hypothesis Results Question Article Posters Peer Review CV+

/Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Author Network

Sort By:

Contributions

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.